Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses

被引:119
作者
Bidra, Avinash S. [1 ]
Pelletier, Jesse S. [2 ]
Westover, Jonna B. [3 ]
Frank, Samantha [4 ]
Brown, Seth M. [4 ,5 ]
Tessema, Belachew [4 ,5 ]
机构
[1] Univ Connecticut, Dept Reconstruct Sci, Hlth Ctr, 263 Farmington Ave,L7039, Farmington, CT 06030 USA
[2] Ocean Ophthalmol Grp, Miami, FL USA
[3] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA
[4] Univ Connecticut, Dept Otolaryngol, Hlth Ctr, Farmington, CT USA
[5] ProHlth Phys Ear Nose & Throat, Farmington, CT USA
来源
JOURNAL OF PROSTHODONTICS-IMPLANT ESTHETIC AND RECONSTRUCTIVE DENTISTRY | 2020年 / 29卷 / 07期
关键词
Corona virus; dental safety; hydrogen peroxide; oral rinse; povidone-iodine; SARS-CoV-2; MOUTHWASHES;
D O I
10.1111/jopr.13220
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose To evaluate the in vitro inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with hydrogen peroxide (H2O2) and povidone-iodine (PVP-I) oral antiseptic rinses at clinically recommended concentrations and contact times. Materials and Methods SARS-CoV-2, USA-WA1/2020 strain virus stock was prepared prior to testing by growing in Vero 76 cells. The culture media for prepared virus stock was minimum essential medium (MEM) with 2% fetal bovine serum (FBS) and 50 mu g/mL gentamicin. Test compounds consisting of PVP-I oral rinse solutions and H(2)O(2)aqueous solutions were mixed directly with the virus solution so that the final concentration was 50% of the test compound and 50% of the virus solution. Thus PVP-I was tested at concentrations of 0.5%, 1.25%, and 1.5%, and H(2)O(2)was tested at 3% and 1.5% concentrations to represent clinically recommended concentrations. Ethanol and water were evaluated in parallel as standard positive and negative controls. All samples were tested at contact periods of 15 seconds and 30 seconds. Surviving virus from each sample was then quantified by standard end-point dilution assay and the log reduction value of each compound compared to the negative control was calculated. Results After the 15-second and 30-second contact times, PVP-I oral antiseptic rinse at all 3 concentrations of 0.5%, 1.25%, and 1.5% completely inactivated SARS-CoV-2. The H(2)O(2)solutions at concentrations of 1.5% and 3.0% showed minimal viricidal activity after 15 seconds and 30 seconds of contact time. Conclusions SARS-CoV-2 virus was completely inactivated by PVP-I oral antiseptic rinse in vitro, at the lowest concentration of 0.5 % and at the lowest contact time of 15 seconds. Hydrogen peroxide at the recommended oral rinse concentrations of 1.5% and 3.0% was minimally effective as a viricidal agent after contact times as long as 30 seconds. Therefore, preprocedural rinsing with diluted PVP-I in the range of 0.5% to 1.5% may be preferred over hydrogen peroxide during the COVID-19 pandemic.
引用
收藏
页码:599 / 603
页数:5
相关论文
共 28 条
[1]   Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse [J].
Bidra, Avinash S. ;
Pelletier, Jesse S. ;
Westover, Jonna B. ;
Frank, Samantha ;
Brown, Seth M. ;
Tessema, Belachew .
JOURNAL OF PROSTHODONTICS-IMPLANT ESTHETIC AND RECONSTRUCTIVE DENTISTRY, 2020, 29 (06) :529-533
[2]   COVID-19: A Recommendation to Examine the Effect of Mouthrinses with β-Cyclodextrin Combined with Citrox in Preventing Infection and Progression [J].
Carrouel, Florence ;
Conte, Maria Pia ;
Fisher, Julian ;
Goncalves, Lucio Souza ;
Dussart, Claude ;
Llodra, Juan Carlos ;
Bourgeois, Denis .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
[3]   Hydrogen peroxide and viral infections: A literature review with research hypothesis definition in relation to the current covid-19 pandemic [J].
Caruso, Arturo Armone ;
Del Prete, Antonio ;
Lazzarino, Antonio Ivan .
MEDICAL HYPOTHESES, 2020, 144
[4]  
Centers for Disease Control and Prevention (CDC), 2020, Guidance for dental settings: interim infection prevention and control guidance for dental settings during the COVID-19 response
[5]   Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis [J].
Chu, Derek K. ;
Akl, Elie A. ;
Duda, Stephanie ;
Solo, Karla ;
Yaacoub, Sally ;
Schunemann, Holger J. .
LANCET, 2020, 395 (10242) :1973-1987
[6]   In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens [J].
Eggers, Maren ;
Koburger-Janssen, Torsten ;
Eickmann, Markus ;
Zorn, Juergen .
INFECTIOUS DISEASES AND THERAPY, 2018, 7 (02) :249-259
[8]  
Foley T P Jr, 1992, Endokrynol Pol, V43 Suppl 1, P53
[9]   Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era [J].
Frank, Samantha ;
Capriotti, Joseph ;
Brown, Seth M. ;
Tessema, Belachew .
ENT-EAR NOSE & THROAT JOURNAL, 2020, 99 (09) :586-593
[10]   I-125 uptake competing with iodine absorption by the thyroid gland following povidone-iodine skin application [J].
Furudate, S ;
Nishimaki, T ;
Muto, T .
EXPERIMENTAL ANIMALS, 1997, 46 (03) :197-202